21.50
30.00
30
30
28.99
30.00
25.00%
37.74%
30.25
198
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
Price-to-book ratio is used to compared the company's current market price with its book value.
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
Technical
The key levels help you plan your entry and exit point.
-
PROFIT & LOSS
Take a quick look at the revenues and expenditure sheet.
-
Balance Sheet
Its a statement of assets, liabilities and share capital.
-
Dividend History
Check out the detailed payout data over the last three years.
-
Comparative Returns
Reveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
-
-
-
-
Moving Average
-
-
-
-
Growth in 3 years
0.00%
Sales Industry Avg
27.58%
PAT
5.56%
PAT Industry Avg
5.53%
Sep 2024 ( in Cr.) | Jun 2024 ( in Cr.) | Mar 2024 ( in Cr.) | Dec 2023 ( in Cr.) | FY 2024 ( in Cr.) | |
---|---|---|---|---|---|
Sales | 0.14 | 0.14 | 0.14 | 0.14 | 0.54 |
Gross Profit | 0.09 | 0.05 | 0.05 | 0.07 | 0.26 |
Operating Profit | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0.09 | 0.05 | 0.04 | 0.07 | 0.25 |
Tax | 0 | 0 | 0.06 | 0 | 0.06 |
Profit After Tax | 0.09 | 0.05 | -0.02 | 0.07 | 0.19 |
-7.26%
Relative to Nifty rtn in 3 year
-13.77%
Relative to top 3 MF rtn in 3 year
1 Year (%) | 2 Year (%) | 3 Year (%) | |
---|---|---|---|
Omkar Pharmachem | 38 | 26 | 27 |
Bse Sensex | 9 | 28 | 29 |
Nifty 50 | 9 | 30 | 31 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
30.00 chg : 1.01 (3.48%)
847.25 chg : -17.25 (-2.00%)
233.00 chg : -12.10 (-4.94%)
56.50 chg : -0.83 (-1.45%)
152.90 chg : -3.10 (-1.99%)
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
Our Research Analysis
__PERCENT__%
Target Achived
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
__Rationale__
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
No data available |
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
---|---|---|---|
No data available |
News
Stay tuned to the latest developments and happenings in the company.
Omkar Pharmachem reports standalone net profit of Rs 0.09 crore in the September 2024 quarter
Net profit of Omkar Pharmachem remain constant at Rs 0.09 crore in the quarter ended September 2024 and also during the previous quarter ended Septemb....
13 Nov 2024 07:40Omkar Pharmachem to announce Quarterly Result
Omkar Pharmachem will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live News</b....
07 Nov 2024 14:15Omkar Pharmachem schedules AGM
Omkar Pharmachem announced that the 29th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital....
23 Sep 2024 17:50Omkar Pharmachem reports standalone net profit of Rs 0.05 crore in the June 2024 quarter
Net profit of Omkar Pharmachem remain constant at Rs 0.05 crore in the quarter ended June 2024 and also during the previous quarter ended June 2023. T....
13 Aug 2024 07:28Omkar Pharmachem to hold board meeting
Omkar Pharmachem will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live News....
05 Aug 2024 11:04Omkar Pharmachem reports standalone net loss of Rs 0.02 crore in the March 2024 quarter
Net Loss of Omkar Pharmachem reported to Rs 0.02 crore in the quarter ended March 2024 as against net loss of Rs 0.01 crore during the previous quarte....
31 May 2024 07:33__heading__
Published on __date__ at __time__
__description__